Organizer
Technology Networks
Technology Networks
Technology Networks explores the science that matters to you, providing access to the latest scientific news, products, research, videos and posters.Technology Networks is part of LabX Media Group, which also owns Lab Manager, LabX, and The Scientist. Technology Networks offer today's scientist a single resource that contains unique, engaging, and entertaining content from their field of research.
Tags
LC/MS
LC/MS/MS
LC/TOF
LC/HRMS
LinkedIn Logo

Characterization of Sequence Modifications in Monoclonal Antibodies

RECORD | Already taken place Tu, 5.12.2023
Using size-exclusion and cation-exchange chromatography with native mass spectrometry and Top-down and middle-down MS on the ZenoTOF instrument to localize modifications on therapeutic mAbs will be discussed.
Go to the webinar
Technology Networks: Characterization of Sequence Modifications in Monoclonal Antibodies
Technology Networks: Characterization of Sequence Modifications in Monoclonal Antibodies

Monoclonal antibodies are considered the most rapidly growing class of therapeutics. Critical quality attributes such as sequence assessment, charge and size variants must be thoroughly monitored since they can alter the biological activities of the product.

Hyphenation of size-exclusion chromatography and cation-exchange chromatography with native mass spectrometry have been widely used to provide a more complete characterization of mAb populations.

Top-down and middle-down mass spectrometry are also emerging strategies for deciphering the structure of proteoforms and the presence of post-translational modifications.

In this webinar, our expert speaker will discuss how these complementary techniques can be performed on the ZenoTOF instrument to localize modifications on therapeutic mAbs.

Attend this webinar to:

Discover how to implement non-denaturing workflows to characterize biotherapeutics

Learn to monitor size and charge variants with very limited sample preparation

Hear how a method for mAb characterization was developed

Explore why localizing post-translational modifications and identifying charge variants is crucial

Presenter: Sarah Nguyen (PhD Student, Strasbourg University - LSMBO)

Technology Networks
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike